
FDA approves GSK’s prefilled syringe presentation of Shingrix
The US Food and Drug Administration (FDA) has approved GSK’s Shingrix vaccine (recombinant zoster vaccine or RZV) in a prefilled syringe presentation to prevent shingles (herpes zoster). This development will streamline the process for healthcare …